COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04461379


Column Value
Trial registration number NCT04461379
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

First author
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

René Rodríguez-Gutiérrez, Dr.MSc.

Contact
Last imported at : Nov. 14, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

rodriguezgutierrez.rene@mayo.edu

Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2020-07-08

Recruitment status
Last imported at : Nov. 4, 2022, 8 a.m.
Source : ClinicalTrials.gov

Unknown

Study design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Prevention

Inclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

inclusion criteria: - health workers who are working onsite in patients' areas with covid-19 - age > 18 years - negative specific igg and igm antibodies test result for sars cov-2 before the enrollment. - provide a signed and dated informed consent form

Exclusion criteria
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

- age <18 years - positive test for specific antibodies igg and igm antibodies result for sars cov-2 - primary or secondary immunosuppression - use of immunosuppression drugs, use of hydroxychloroquine, cloroquine, azithromycin, lopinavir/ritonavir, ivermectin or any other drug used to treat patients covid-19 before the enrollment. - chemotherapy treatment - presence of antibodies iga, igm, igg against sars-cov-2 - pregnancy or breastfeeding - missing informed consent form - fever > 38° in the previous 24 hours - any bcg vaccine contraindication - history of previous allergy to the components of the vaccine - already part of any other trial - previous or active tuberculosis (tb) disease - another vaccine administrated 4 months before the start of the trial. - any underlying history of malignancy or lymphoma. - actual treatment with steroids - absence of more than 1 month from the hospital, from the study period.

Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Hospital Universitario Dr. Jose E. Gonzalez

Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Mexico

Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Health workers

Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

908

primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

Critical care admission with SARS-CoV2;Demonstrate COVID- 19 disease incidence among Health care workers:;Demonstrate cumulative incidence of hospitalization for COVID-19 among Health care workers:;Demonstrate the Incidence of specific Antibodies against SARS-CoV-2 at 3 and 6 months in health care workers;Hospitalization of severe disease COVID-19;Oxygen supplementation in severe disease COVID-19;Mortality associated to progressive pulmonary disease;Need for intubation or non-invasive ventilation for the patient.

Notes
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Feb. 25, 2021, 7:58 p.m.
Source : ClinicalTrials.gov

Phase 3

Arms
Last imported at : Oct. 26, 2020, 11:31 p.m.
Source : ClinicalTrials.gov

[{"arm_notes": "1", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "1", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}]